Search

everythinglearnresearchcommunity

for

Search:↓

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Modulating the BTNL2 pathway can prevent hair loss in mice.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Apremilast may help treat hair loss in alopecia areata.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Denosumab treatment for osteoporosis can cause hair loss.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

BST2 protein and certain T cells increase in early alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Vitiligo treatments are improving but relapses are common.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.